Insider Transactions in Q3 2024 at Xtant Medical Holdings, Inc. (XTNT)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 15
2024
|
Stavros G. Vizirgianakis Director |
BUY
Grant, award, or other acquisition
|
Direct |
748,648
+5.2%
|
-
|
|
Aug 15
2024
|
Lori D Mitchell Keller Director |
BUY
Grant, award, or other acquisition
|
Direct |
162,162
+31.47%
|
-
|
|
Aug 15
2024
|
Robert Mc Namara Director |
BUY
Grant, award, or other acquisition
|
Direct |
162,162
+17.7%
|
-
|
|
Aug 15
2024
|
Jonn R. Beeson Director |
BUY
Grant, award, or other acquisition
|
Direct |
162,162
+31.09%
|
-
|
|
Aug 15
2024
|
John K Bakewell Director |
BUY
Grant, award, or other acquisition
|
Direct |
162,162
+17.66%
|
-
|
|
Aug 15
2024
|
Kevin D Brandt Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
56,333
-5.63%
|
$0
$0.6 P/Share
|
|
Aug 15
2024
|
Scott C Neils Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
34,132
-5.14%
|
$0
$0.6 P/Share
|
|
Aug 15
2024
|
Sean E Browne President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,606
-0.46%
|
$0
$0.6 P/Share
|